STML - Stemline Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed price. Currency in USD
-0.05 (-0.36%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous close14.05
Bid11.10 x 5000
Ask20.00 x 200
Day's range13.70 - 14.10
52-week range5.50 - 14.60
Avg. volume276,098
Market cap354.02M
PE ratio (TTM)N/A
EPS (TTM)-2.47
Earnings date6 Nov 2017 - 10 Nov 2017
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est31.00
Trade prices are not sourced from all markets
  • Associated Press9 days ago

    Stemline Therapeutics reports 3Q loss

    The New York-based company said it had a loss of 68 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a ...

  • We're sorry this is all we were able to find about this topic.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes